GFM

GF Fund Management Portfolio holdings

AUM $4.97B
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
701
New
Increased
Reduced
Closed

Top Buys

1 +$31.2M
2 +$28.7M
3 +$28.4M
4
UNH icon
UnitedHealth
UNH
+$25.3M
5
CLS icon
Celestica
CLS
+$20.1M

Top Sells

1 +$36.5M
2 +$32.1M
3 +$28.1M
4
BEKE icon
KE Holdings
BEKE
+$20.4M
5
TCOM icon
Trip.com Group
TCOM
+$16.6M

Sector Composition

1 Technology 46.23%
2 Consumer Discretionary 14.24%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
601
Monte Rosa Therapeutics
GLUE
$610M
$7.09K ﹤0.01%
1,572
ALT icon
602
Altimmune
ALT
$353M
$7.05K ﹤0.01%
1,821
VNDA icon
603
Vanda Pharmaceuticals
VNDA
$315M
$7.05K ﹤0.01%
1,493
CBL
604
CBL Properties
CBL
$900M
$6.93K ﹤0.01%
273
+42
HUMA icon
605
Humacyte
HUMA
$339M
$6.89K ﹤0.01%
3,295
SLN
606
Silence Therapeutics
SLN
$340M
$6.76K ﹤0.01%
1,165
RNAC icon
607
Cartesian Therapeutics
RNAC
$254M
$6.75K ﹤0.01%
650
TKNO icon
608
Alpha Teknova
TKNO
$308M
$6.7K ﹤0.01%
1,365
FHTX icon
609
Foghorn Therapeutics
FHTX
$228M
$6.69K ﹤0.01%
1,424
ANNX icon
610
Annexon
ANNX
$347M
$6.55K ﹤0.01%
2,729
TRDA icon
611
Entrada Therapeutics
TRDA
$238M
$6.44K ﹤0.01%
958
CRVS icon
612
Corvus Pharmaceuticals
CRVS
$557M
$6.38K ﹤0.01%
1,594
INZY
613
DELISTED
Inozyme Pharma
INZY
$6.18K ﹤0.01%
1,544
THRD
614
DELISTED
Third Harmonic Bio
THRD
$6.07K ﹤0.01%
1,118
ALLO icon
615
Allogene Therapeutics
ALLO
$286M
$6.07K ﹤0.01%
5,368
OLMA icon
616
Olema Pharmaceuticals
OLMA
$533M
$6.06K ﹤0.01%
1,422
ETR icon
617
Entergy
ETR
$43.2B
$5.99K ﹤0.01%
72
-8,939
MXCT icon
618
MaxCyte
MXCT
$187M
$5.89K ﹤0.01%
2,701
RCKT icon
619
Rocket Pharmaceuticals
RCKT
$432M
$5.72K ﹤0.01%
2,333
NGNE icon
620
Neurogene
NGNE
$459M
$5.5K ﹤0.01%
368
OABI icon
621
OmniAb
OABI
$249M
$5.39K ﹤0.01%
3,099
TVGN icon
622
Tevogen Bio Holdings
TVGN
$138M
$5.26K ﹤0.01%
4,207
INBX icon
623
Inhibrx
INBX
$554M
$5.12K ﹤0.01%
359
YMAB
624
DELISTED
Y-mAbs Therapeutics
YMAB
$5.01K ﹤0.01%
1,111
ACIU icon
625
AC Immune
ACIU
$297M
$4.98K ﹤0.01%
2,454